S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 3.31 USD 1.53% Market Closed
Market Cap: 216.4m USD
Have any thoughts about
Sophia Genetics SA?
Write Note

Sophia Genetics SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sophia Genetics SA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Sophia Genetics SA
NASDAQ:SOPH
Total Liabilities & Equity
$206.2m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascom Holding AG
SIX:ASCN
Total Liabilities & Equity
CHf200.2m
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
-8%
No Stocks Found

Sophia Genetics SA
Glance View

Market Cap
219.9m USD
Industry
Health Care

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

SOPH Intrinsic Value
4.3 USD
Undervaluation 23%
Intrinsic Value
Price
S

See Also

What is Sophia Genetics SA's Total Liabilities & Equity?
Total Liabilities & Equity
206.2m USD

Based on the financial report for Dec 31, 2023, Sophia Genetics SA's Total Liabilities & Equity amounts to 206.2m USD.

What is Sophia Genetics SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
16%

Over the last year, the Total Liabilities & Equity growth was -15%. The average annual Total Liabilities & Equity growth rates for Sophia Genetics SA have been 16% over the past three years .

Back to Top